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Abstract
Introducing biochemical factor to electronic devices have created a new branch of science. 
Recent development in biosensing technology enabled progress in pathogens detection. 
Currently, wide range of biomarkers (enzymes, peptides, DNA, microorganisms, etc. ) 
recognize various target analytes, starting from basic metabolism changes to serious 
infections caused by pathogens. Improved sensitivity, selectivity and response time of 
sensors have instantly replaced traditional techniques. Easy handling, low production 
costs and miniaturization have met therapeutics need. Biosensing technologies are very 
strong point in telemedicine in public healthcare. This chapter will focus on electrochem-
ical techniques for pathogens detection and show trending applications in biosensing 
technologies.
Keywords: sensor, biosensing technology, bioelectronics, electrochemistry, impedance 
spectroscopy, cyclic voltammetry, immobilized electrode, nanomaterials, noble metal 
nanoparticles, recognition element, human pathogen, pathogens detection, virus, 
bacteria, DNA, markers, diseases, telemedicine, point-of-care, lab-on-chip
1. Introduction
The biosensor era have started in 1962 by invention the first glucose meter by Clark and 
Lyons [1] and speeded up in uncontrollable pace. Currently, it embraces fields such as bio-
telemedicine, biology, environmental monitoring, drug discovery, food safety controlling and 
others. The term ‘biosensor’ stands for the electronic analytical device incorporated with bio-
logical sensing element and physiochemical transducer [2, 3]. The main biosensors success 
was achieved by transforming technological sophisticated machines to small handy devices. 
© 2018 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
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Especially, electrochemical biosensors are in main interest. Implementation of biological fac-
tors to electronic devices have improved sensitivity, selectivity, limits of detection (LODs) 
and limits of quantification (LOQs). Also miniaturization, simplification and portability have 
made them user-friendly and available for large audience of non-specialists and patients.
2. Biosensors classification
Biosensors classification mainly relies on the receptor and transducer type and is represented 
in Table 1 [2, 4, 5]. Besides the suitable measurement technique used, the biosensor have 
to meet the requirements, which are detection limit, linear response range, response time, 
sensitivity and selectivity, stability and reproducibility. New types of biosensors are being 
developed, transducer hybrids, like photoelectrochemical [6].
Great sensing development can be observed in electrochemical field. Initially detected ana-
lytes were basic chemical compounds like glucose, urea, subsequently macromolecules like 
proteins, whole cells, viruses, bacteria and other pathogens. Currently, it is possible to follow 
antigen-antibody interactions, detect tumor markers, DNA materials, etc.
3. Electrochemical detection
Electrochemical biosensors are devices containing electrochemical transducer. They provide 
semiquantitative or quantitative analytical information, thanks to biochemical receptor. Electrical 
changes due to reduction/oxidation reactions of analyte can be analyzed in different ways. In this 
case, measured properties are current or potential. The principle is the change of solution proper-
ties due to production/consumption of electrons that is measured relatively to always stable ref-
erence electrode. The process depends on the species activity, not on the solution concentration, 
because it is focused on the working electrode surface. There are also electrochemical techniques 
Table 1. Biosensors classification based on bioreceptor and transducer types.
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which do not use direct electron flow and do not focus on the redox reaction. For example, the 
changes of electrode’s surface deriving from surface biofunctionalization and molecular inter-
actions like antigen-antibody, receptor-ligand and others are analyzed. In this case, measured 
parameters are resistance, capacitance or impedance. The easy way of transforming a biological 
interaction to simple electrical signal makes it attractive for sensor industry. The strong advan-
tage is a wide range of electrical properties which can be measured and quantified with meth-
ods like potentiometry, amperometry, voltammetry, conductometry and impedance (described 
below). Moreover, multiple electrode materials used as receptors and methods of their immobi-
lization are available [7].
3.1. Electrochemical cell
The conventional electrochemical cell contains three separate electrodes: the working electrode 
(WE), the counter electrode (CE) and the reference electrode (RE). The WE material must be 
a chemically stable conductive material, such as carbon, gold, platinum and more. The redox 
process occurs on the surface, so can be polarized both, cathodic and anodic, depending on 
analyzed reaction. The electrode material strongly influences the measurement because every 
material has different parameters, such as potential window, capacity. The WE should have 
high reproducibility and S/N characteristics. The toxicity and costs are also important. The 
CE (auxiliary electrode) provides electron flow between WE and CE and closes the current 
circuit in the cell. The CE surface area must be much larger than WE, to avoid kinetic limit of 
the process. It can be carbon, platinum wire. The RE produces constant potential in whole cell, 
balances the WE reaction. Requirements are low impedance and non-polarizability. The most 
common RE is standard hydrogen electrode (SHE) with a zero half-cell potential or silver wire 
coated with silver chloride [2, 7].
Except conventional electrochemical cell with three electrodes, there are variations and min-
iaturized versions. Microfluidic cells concept offers easier sampling and cleaning, enhanced 
sensitivity and reduced interferences [8]. Obviously fewer reagents are consumed and less 
waste is generated. For example, the microbial fuel cell (MFC) can convert organic substrates 
by microbial catabolism to electrical signal [3]. On the lab-on-a-chip devices (LOC), the three 
electrode system is miniaturized to few centimeters square platform with multiple laboratory 
functions. It is possible to handle very small fluid volumes (picoliters level) [7]. Screen-printed 
electrodes (SPEs), three-minielectrodes are deposited or printed onto polymer substrate form-
ing ultrasmall measuring system. They are mass produced with high reproducibility and low 
costs. This set allows easy modifications of WE surface [2, 9].
3.2. Electrochemical sensor: potentiometric detection
Potentiometric sensors measure the potential change at one electrode referred to another elec-
trode. The electrical potential difference or electromotive force (EMF) is measured at zero 
current value [4]. For example, the potential is formed when antigen-antibody interaction 
occurs. The reaction is described by the Nernst equation. Concentration response is logarith-
mic, allowing very small changes detection [2, 7]. Zelada-Guillén et al. has first applied this 
technique for Staphylococcus aureus detection in real-time. Single-walled carbon nanotubes 
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(SWCNTs) were used as transducer and functionalized with anti-S. aureus aptamers by two 
approaches. In covalent functionalization, LOD was 8 × 102 colony-forming units (CFU)/
mL. Non-covalent approach has had higher sensitivity but LOD was 107 CFU/mL level [10].
3.3. Electrochemical sensor: conductometric detection
Conductometric transducers measure variation of the ionic strength of a solution, which 
changes current flow or electrical conductivity. Despite the few advantages like low-priced 
thin-film applications [4], direct real-time monitoring [7], no reference electrode need and 
miniaturization possibilities, this technique gives less sensitive responses than others elec-
trochemical methods [2]. Hnaiein et al. have implemented this technique for Escherichia coli 
detection. Authors have used streptavidin-functionalized magnetite nanoparticles which 
interact with biotinylated antibodies, anti-E. coli. Detection on 1 CFU/mL level causes 35 μS 
conductivity change [11].
3.4. Electrochemical sensor: amperometric detection
Amperometric transducers measure the direct current from redox reaction under a constant 
potential applied on WE. The activity of recognition element varies before and after interac-
tion with a target molecule [4]. The product must be electroactive and undergoes a redox 
process [12]. The current is a rate of the electrons transferred and is proportional to the ana-
lyte concentration [2, 7]. Singh et al. have invented novel DNA-based amperometric sensor 
for one of the most common human pathogens—Streptococcus pyogenes. Gold nanoparticles 
were functionalized with cysteine, PAMAM and genomic single-stranded DNA (ssDNA). The 
amperometric response was measured after DNA hybridization, with sensitivity of 951.34 
(μA/cm2)/ng DNA and LOD with 130 fg/6 μL sample. Sensor was suitable for throat swabs 
and needed 30 min for pathogen identification [13].
3.5. Electrochemical sensor: voltammetric detection
Voltammetric transducers are the most comprehensive and mostly used by research groups 
in biosensing analysis. Sensor measures the current-potential relationship. The potential 
is measured in ‘no-current applied’ conditions [12]. The potential where the redox peaks 
appear is specific for the examined species and the current peak size is proportional to the 
species. It is possible to detect many compounds with different characteristic potentials in 
one measurement. Voltammetric methods can be further divided into: cyclic voltammetry 
(CV), differential pulse voltammetry (DPV), stripping voltammetry, AC voltammetry, polar-
ography, linear sweep voltammetry (LSV) etc., however, the most commonly used are CV, 
DPV and LSV. The difference is in the way of potential application [2]. The simplest is LSV, 
where at WE, the potential applied increases linearly in time. The flowing current consists 
of the faradaic current (flowing the Faraday laws, means discharging of active compound) 
and capacitive current (produced due to double electric layer growth between the solution 
and electrode). Detection limits are at mg/L level. In CV, scanning has a triangular shape 
characteristic. Obtained voltammogram is a closed curve with redox peaks (two if process is 
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reversible, one if process is irreversible). The low sensitivity makes CV inapplicable for quan-
titative analysis. DPV principle is applying periodical constant potential pulse during linear 
scanning. Measured is the difference between the current before and after the pulse giving 
one peak-graph. This technique is very sensitive with detections on 10–100 μg/L limit [2].
3.6. Electrochemical sensor: impedimetric detection
Very strongly exploited are impedimetric transducers. The method, called electrochemical 
impedance spectroscopy (EIS), characterizers the structure and function of electrodes, espe-
cially modified with biological material [14]. It can be further classified as Faradaic or non-
Faradaic depending on the presence/absence of redox probe in the solution. The second one 
is more preferred in point-of-care (POC) devices due to no reagents need. During immobi-
lization of electrode surface, the resistance and capacitance of a double-layer are changing, 
causing change in the impedance. Thus, the biorecognition process and label-free interactions 
on the sensor surface can be detected [7]. Two most popular results are expressed as Nyquist 
and Bode plots. EIS sensors are mainly constructed by self-assembled monolayer (SAM) or a 
conducting polymer base layer method [12]. Detection limits are worse comparing to potenti-
ometric or amperometric methods. False positive results derived from the electrolytes are the 
main drawback. It can be overcome by blocking the non-specific binding sites of the electrode 
surface with, for example, BSA protein [4]. The immunoreaction between antigen and anti-
body directly indicates impedance changes. Nidzworski et al. have presented the universal 
biosensor for influenza A virus detection. The principle was attaching appropriate antibodies 
to gold electrode which detect viral M protein. The difference of electron-transfer resistance 
was observed before and after influenza virus addition and peptide-antibody interaction. 
Increasing concentration of peptide causes the increase of resistance. The main advantage 
was no need for sample pretreatment, just swab suspension in buffer solution. Sensitivity was 
80–100 virions/μL [15].
4. Importance of sensing materials choice
The wide range of working electrode materials and the variety of electrode surface bio-
functionalization methods [7] make the electrochemistry very strong scientific and industry 
branch. The choice of active material and functionalization mechanism depends on the type of 
molecular recognition between the receptor and target analyte. Working electrode materials 
enhance electroactivity and promote electron-transfer reaction, but differ in reactivity, con-
ductivity and stability so interacts diversely with chemical or biological molecules.
Noble metal nanoparticles (NPs) due to great conductivity, biocompatibility, high surface-
to-volume ratio and modification possibilities by hybridization, sol-gel, self-assembly 
monolayer (SAM) and others methods are very popular and available on the market [16]. 
Currently, nanomaterials are essential in bio-devices due to enhanced sensitivity and detec-
tion limits [17]. Well-known are AuNPs, AgNPs, PtNPs, and their alloys Au-Ag, Au-Pt, 
Ag-Pt [16]. For example, Liu et al. have used AuNPs combined with BamHI endonuclease 
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for Hepatitis C Virus RNA detection by DPV technique with LOD 3.1 × 10−22 M [18]. Li et al. 
have detected gene fragments from Hepatitis B Virus, also by DPV, but introducing AgNPs 
and LOD was 1 × 10−18 M level [19].
Next appreciated materials are (nano-)carbon components, such as carbon nanotubes [20] 
or carbon nanowires with high stability, great mechanical strength and good conductivity, 
glassy carbon materials or graphene-based sensors [21, 22]. Bhardwaj et al. have fabri-
cated cheap paper-based sensor for detection of foodborne pathogens: E. coli, B. subtilis and 
S. epidermidis. Authors have used single-walled carbon nanotubes (SWCNTs) conjugated 
with corresponding antibodies (Ab). Covalent attachment of Ab-SWCNTs has increased 
the stability of a sensor. Measurement technique was DPV. This fast, label-free method 
had LOD on 13 CFU/mL level with linear concentration range from 10 to 107 CFU/mL [23]. 
Gong et al. have proposed impedimetric DNA biosensor for HIV-1 gene determination. 
Glassy carbon electrode was modified with graphene-Nafion composite and ssDNA. The 
decrease in the resistance was proportional to gene concentration in a range from 1.0 × 10−13 
to 1.0 × 10−10 M with LOD at 2.3 × 10−14 M [24].
Silica is willingly used due to no toxicity, biocompatibility, significant electronic, optical and 
mechanical properties [17, 25]. Nguyen et al. have used magnetic silica nanotubes (MSNTs) 
for label-free Salmonella typhimurium detection. A positively charged surface of silica attracted 
bacteria adsorption. This complex interacted with antibody-immobilized gold electrode. 
Impedance sensor showed linear signals for 103–107 CFU bacterial concentration. In authors 
opinion, MSNTs material have a better LOD and sensitivity than other nanomaterials in 
impedimetric immunosensors [26].
5. Technological comparison
The biosensors will be necessary to provide the consumers with sensing devices having short 
analysis time, low costs, satisfactory LODs and LOQs, portability possibilities, etc., as it was 
in the case of glucose meters and pregnancy tests. Electrochemical methods will be compared 
to optical, piezoelectric and others in reference to technology, detection limits, linear range 
and specificity.
In optic-based biosensors, single molecule detection, such as DNA, can be done [27]. This 
technology was later improved due to innovations like combination of biological materials. 
Also, mixing different optical components on one sensor enables forming multisensing device 
on a single chip and swift analysis. Hybrids of fluorescence and nanomaterials or biomol-
ecules increase application possibilities and sensitivities. However, the main drawbacks are 
costs and strict instruments requirements [17]. Optical SPR detection is the most evaluated 
and calibrated technique for real-time and label-free assays [7]. Piezoelectric devices also offer 
real-time and label-free analysis, but stand out with the flexibility and low costs, compared 
to optical methods. Thus, it can be ideal for detection methods optimization [28]. However, 
from all biosensor types (microbial, electromagnetic, optical and electrochemical), only elec-
trochemical are able to detect both, single or multiple, analytes with the real-time analysis and 
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satisfying (but not the highest) sensitivity [17]. Thus, the electrochemical transducers seem to 
be the most beneficial. They are widely used in POC devices which are on-site diagnostic tests 
accessible to the physicians and patients, thanks to user-friendly handling and portability [29]. 
Another positive aspects are sensitivity, specificity with real-time analysis. Cost values are 
fluctuating, however they are not the highest (comparing to optical devices) and available for 
many laboratory industries. Currently, the electrochemical instruments are being miniatur-
ized to hand-size. Application does not require laboratory conditions; simple instrumentation 
enables analysis in physician’s offices or patient’s houses. They are the smallest from all the 
sensors and with the strongest future perspectives [2, 17]. Biosensors industry offers hybrid-
methods, such as photoelectrochemistry. The principle is to activate the species on electrode 
surface by the light, and received photocurrent is detected. The assay has advantages deriv-
ing from both methods. High sensitivity is gained from separated excitation and detection 
sources. Comparing to whole-optical methods such as fluorescence, exchanging detection to 
electrochemical lowers the costs and simplifies the instrumentation. Moreover, implementa-
tion of photoelectrochemical active nanomaterials can be very beneficial for hybrid assays [7].
6. Non-invasive, wearable biosensors
In everyday life, the superior analysis is with so-called ‘non-invasive’ biosensors, where there 
is no interruption in patient’s body, what happens in blood or serum collecting. Non-invasive 
specimens are saliva, sweat and tears. The basic example can be breathalyzer for blood alcohol 
content from a breath sample. The main promise of non-invasive techniques, such as polar-
imetry or impedance, is non-stop monitoring with real-time results for optimal health status 
maintaining and deterioration warning. These solutions can help reduce health care costs and 
time spent in hospitals [7]. Glucose, alcohol, illness-causing pathogen like influenza virus and 
others can be detected from the samples [30, 31].
Tears are rich in proteins, lipids, metabolite and electrolytes and are used for diabetes moni-
toring. Saliva analysis can show changes in metabolic, hormonal or even emotional human 
body states [2]. For example, Kim et al. have invented the wearable mouthguard sensor for 
uric acid detection as end product of purine metabolism in saliva specimens. Abnormalities 
indicate diseases like hyperuricemia, gout or Lesch-Nyhan syndrome. Enzyme-modified 
printed electrode shows amperometric response and is connected to the platform sending 
analysis results to smartphones and laptops [32]. By breath analysis, viruses causing respira-
tory infections can be detected [33]. Others wearable biosensors are blood pressure sensor, 
temperature sensor, breathing sensor for respiration monitoring or so-called ‘smart socks’ 
used to individual step characterization [34].
7. Applications
Many biosensors have found everyday appliance, not only the laboratory usage. The main 
goal of biodevices is to be implemented in medical field. It means detect human illnesses, 
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thus mutations, infections at first stages, pathogens, as ‘prevention is better than cure’. 
Pathogens including bacteria, viruses, fungi, protozoa and are one the main human death 
causes. They have many transmitters like human, animals and plants [35], thus unchecked 
can cause pandemics. Early diagnosis is one of the strongest prevention method, but still 
challenging due to high costs, strict sample preparation mechanisms and long-time analy-
sis. Modern technology biosensors can overcome these drawbacks by device miniaturiza-
tion or rapid data output. Nowadays detection is possible from common illnesses like virus 
invasions to serious tumors, due to wide range of bioreceptors and measurement tech-
niques mentioned above. Biosensors application, except human health, is in food process-
ing/monitoring, fermentation processes, biodefence in military and many more described 
in this chapter.
Biological defense sensors are sensitive for organisms posing threat, called biowarfare agents 
(BWAs), such as bacteria, viruses and toxins. Most used are molecular techniques recognizing 
BWAs markers, more preferably nucleic acid-based than antibody-based due to higher sen-
sitivity and specificity. An example is detection of genomic DNA of HPV virus by modified 
surface acoustic wave (SAW) biosensor [36].
Nano-based biosensors are one of the most willingly investigated and applied due to sig-
nificant properties described in Section 4. For example, nanomaterials are able to detect 
antibiotics residues in human body which decrease the treatment efficiency [37]. Others 
specific interactions were carried on porous silicon, for example, for E. coli detection [38]. 
There are also silica-modified materials, by Hg2+ ions [39] or Ag/graphene/silica compos-
ites [40]. Quantum dots technology can be used for tumor analysis (targeting ligands can be 
monoclonal antibodies and peptides) and for nano-medicine delivery [17]. Engineered NPs 
thrive in POC devices. AuNPs combined with magnetic MNPs can detect mecA gene which 
is a biomarker for methicillin-resistant S. aureus (MRSA) at concentration 10 pM of targeted 
DNA. Optical SPR method acts as HBV sensor using AuNPs with LOD 2 fg/mL and 17 min 
analysis time. Another material, cadmium tellurite QDs conjugated to silica NPs enhanced 
the signal of Epstein–Barr virus detection. The square wave voltammetry measurements 
resulted in LOD of 1 pg/mL [29]. For more examples of pathogens nanodiagnostics, view  [41], 
from all nanomaterials, the main interest arouses the gold. Except biosensing application, it is 
used in drug delivery or photothermal therapy. Gold nanoparticles are the most stable, have 
activity to biomolecules, significant optical properties depending on environment. In colo-
rimetric methods, it is used for foodborne, waterborne or hospital pathogens detection. The 
majority of these assays use SPR technique. The peak absorbance of AuNPs highly depends 
on their shape (nanorods, star-shaped and more) and size. By DNA targeting, it is possible 
to detect Salmonella species, Bacillus anthracis, Chlamydia trachomatis bacteria or HIV-1 and 
H1N1 influenza viruses. Another use is Leishmania major, a protozoan parasite, detection by 
gold nanorods. Gold as signal enhancer can be used as non-functionalized or functionalized 
with nucleic acids and proteins [35]. Simplification of the detection process is required for 
bringing nanoparticles to POC field. User-friendly devices can be achieved by phone-based, 
strip-based solutions which already exist on the market.
Except optical detection, gold is often implemented in electrochemical techniques.
Biosensing Technologies for the Detection of Pathogens - A Prospective Way for Rapid Analysis158
Davies et al. have developed amperometric biosensor for Listeria monocytogenes in food sam-
ples. Authors have modified screen-printed carbon electrode with gold nanoparticles and spe-
cific antibodies. AuNPs have increased the reaction surface and conductivity of the material 
and lowering the LOD to 2 log CFU/mL in blueberry samples [42]. Yang et al. have reported a 
sensor for Salmonella spp. detection where AuNPs acted as self-assembled layer on glassy car-
bon electrode and increased the sensitivity and selectivity. Pathogen presence was recorded 
by EIS method with LOD 100 CFU/mL [43]. Gaffar and Nurmalasari have invented DNA 
biosensor with thiol-modified gold electrode for of M. tuberculosis oligonucleotide sequence 
detection. Complementary ssDNA were immobilized on SAM of thiol and further used for 
target DNA hybridization. DPV was chosen as measurement technique for guanine oxidation 
signal monitoring. LOD is 2.7046 μg/mL and LOQ is 9.0155 μg/mL with accuracy of 99.22% 
and precision of 99.86% [44].
Aptamer-based systems have recently gained big potential in bacterial pathogens recogni-
tion. This method is applicable for food and clinical probes and offers excellent sensitivity and 
less time than traditional methods. Aptamers are called nucleic acid analogues of antibodies 
and are chosen via traditional SELEX technique. Main advantages are high surface density, 
thus better binding properties, temperature stability, easy chemical synthesis comparing to 
monoclonal antibodies. Alizadeh et al. have reviewed aptasensors for microbial pathogens. 
Authors showed detection of Gram-positive bacteria, S. aureus (by tyramine signal amplifi-
cation (TSA) detection method with LOD of 9 CFU/mL in milk sample), Salmonella spp. (by 
non-covalent self-assembly of SWNTs with LOD of 103 CFU/mL in food, clinical and environ-
mental samples), E. coli (by flow cytometric method with LOD of 1.1 × 103 CFU/mL in pure 
culture sample), M. tuberculosis, S. mutans, etc. [45].
Microbial biosensors can monitor fermentation processes. For example, isolated bacteria, like 
C. tropicalis, G. oxydans can determine ethanol generated during fermentation. Others, like 
L. bulgaricus or S. thermophilus are used for glucose or lactose control [3]. The World Health 
Organization (WHO) invented a criteria for diagnostic tests development called ‘ASSURED’ 
meaning Affordable, Sensitive, Specific, User-friendly, Rapid, Equipment-free, Delivered to 
those in need. Sensitivity and specificity are required on 85–95% levels [46].
In viruses, the main goal is to detect them at very low level, at the beginning of human or 
animal infection, it allow the doctor for applying appropriate treatment. Currently, viruses 
are being detected with time consuming methods, like cell culture protocols (2–10 days) or 
enzyme-linked immunosorbent assay (ELISA) related to viral antigens. Clinical microbiology 
is limited due long-time process of isolation and detection of microorganisms [46]. Enzyme-
linked immunosorbent assay (ELISA) recognizes the antibodies specified to the target anti-
gens with optical response. There are commercially available kits willingly used in clinical 
laboratories. However, this technique still suffers from long time and multistep analysis, 
need specialized handling and does not offer satisfying sensitivities. Another technique is 
polymerase chain reaction (PCR) with nucleic acid amplification for concentration increase 
of target DNA sequence, thus offering high sensitivities to even single gene copy. Specificity 
depends on primers design. Interferences from non-targets cause mismatches and non-
specific amplifications, but are overcome by newest techniques like real-time PCR, reverse 
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transcription PCR [5, 35]. The sensitivities between known assays are PCR with 5–100 tissue 
culture infection dose at 50% endpoint (TCID
50
), cell culture with 104 TCID
50
 and ELISA with 
105 TCID
50
. For these reasons a rapid, sensitive, cheap device is pivotal [12]. Virus detec-
tion receptors are mainly antibodies, peptides, aptamers and nucleic acids. Antibodies are 
believed as most common, because are produced as immune response in host organism in 
the presence of foreign species [2]. They can bind with high affinity (K
d
 106–109 M) [12]. Next 
are peptides, short amino acid monomers chains. They have specific binding properties to 
viral proteins or antibodies with high stability. Nucleic acids bind specific, complementary 
viral (also bacterial) RNA and DNA. Viruses can be also detected by electrochemical methods 
[15]. By CV and DPV techniques, HBV virus can be detected with LOD 1.94 × 10−8 M of target 
DNA [47]. EIS method is widely used for many pathogens detection, like influenza virus [48], 
dengue virus [49], HIV [50], rabies virus [51] and others. From optical methods, SPR was the 
key for many develops in HIV virus issue, like developing new antiviral drugs [52]. SPR has 
a potential to be portable rapid viral test, however miniaturization is limited. Optical fiber 
methods were applied for Ebola virus antibodies detection down to 1 ppm or for HCV RNA 
quantification with LOD at 60 pM [53].
Among all mentioned applications, especially environmental and medical need simple, fast 
and very sensitive devices, what is available with immobilizers like gold, carbon materials, 
silica and others. The discovery of electrochemical biosensors became essential in POC [54] 
and clinical diagnosis [55]. An early disease monitoring is pivotal in adequate treatment.
Lab-on-chip solutions have broad recent scientists’ attention, especially fluidic assays due to 
sample transport improvement, time saving, reduced volumes and dimension of microfluidic 
channels, making analysis possible in one blood drop. This kind of biosensors includes elec-
trochemical-based, optical-based, micromechanical-based transduction and others. Detection 
of many pathogens has been reported, like Ebstein-Barr Virus [56], human immunodeficiency 
virus [57], Salmonella typhimurium [58], H5N1 influenza [59] and more. For more examples, 
please see [60] .
Following the newest researches, we have described the most interesting examples. Ganguli 
et al. have proposed smartphone-based POC sensor for Zika, chikungunya and dengue 
viruses detection. Blood sample was collected and applied to pre-processing module, where 
automated mechanism mixed the sample with lysis buffer and RT-LAMP reagents. The mix-
ture next went to the amplification chip where reaction was incubated. After that, the LED 
from cellphone was switched on for sample illumination. Real-time fluorescence results were 
displayed on the screen. If the channel lighted up, the pathogen was presented. LOD for Zika 
was 10 PFU in 25 μL sample what corresponds to 6250 PFU/mL in blood [54].
A big part of sensing techniques are smartphone-based devices as their components are ideal 
for common analytical readers such as a screen acting as display and controller, a camera as 
input for signal capturing, a memory for data storing, connectivity modes (Bluetooth, NFC 
and Wi-Fi) for data transmission. Also, GPS can help track global health in serious cases like 
pandemic. Wear possibilities and portability makes it powerful branch in biosensing area. 
The second fact, they are not expensive devices with high accessibility, as there are billions of 
mobile phone users globally. Smartphone devices are classified as detectors or instrumental 
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interface for controlling the experiment setup, but this solution is less reported in the litera-
ture. This classification means to make a device that can be attached to the smartphone or 
make independent device and connect it with a smartphone via Bluetooth, etc. Adapters are 
often required for proper distance maintaining between the sample and the camera or for 
dark chambers making (in fluorescence). Main attention attracts optical methods, however 
microscopic, magnetoresistive and electrochemical are also available. The next big advan-
tage is costs reduction. Applications are pH measurements [61], heart rate scanning [62] and 
others. Noteworthy is that phone’s microphone can perform spirometry (lung capacity) by 
blow-sound measurement. Great idea was to introduce phone sensors platforms to drones for 
reaching difficult places and providing low weight portable laboratories for human in need 
[63, 64]. For a critical review, more application examples and commercially available biosen-
sors please see [65].
The point-of-care (POC) diagnostics is the next branch with intention of public health revolu-
tion. Rapid disease diagnosis is essential for the accurate treatment. In developed countries, 
most analysis are performed in traditional way-in specialized laboratories with sophisticated 
equipment and by qualified personnel. Thanks POC testing allows for in vitro diagnostics 
with results obtained at ambulances, accident sites or physician’s offices. Moreover, self-test-
ing will be provided for patients. The strong advantages are small size, portability and auto-
mation, like in smartphones. Actually, smartphones can be classified as POC devices. Many 
products are currently available on the market, like glucose sensors, pregnancy tests, urine 
screening and more. The microelectromechanical systems (MEMS) technology is strongly 
introduced to POC assays. The main advantage is separating, mixing, isolating and more 
sample treatment steps in one device. Main target analytes are proteins, nucleic acids, cells 
(blood cells), small molecules (metabolites such as glucose and cholesterol). With features 
as time-efficiency, easy operating and portability, they are ideal for use in poor countries 
and difficult geographical regions. Many POC devices use microfluidic assays as paper-based 
microfluidics are disposable, cheap and easy to storage. However, these microfluidic solutions 
can only show qualitative answers (yes/no for the presence of target analytes). Challenging is 
the choice of appropriate marker and optimization of accuracy, sensitivity, speed and more 
parameters. One of the biggest potential in POC devices is detection of circulating tumor cells 
for cancer progression monitoring by atomic force microscopy technique. Others common 
label-free assays are filtration, hydrodynamic chromatography and dielectrophoresis [66, 67]. 
For more point-of-care sensors, authors recommend reading [68].
The novel pathogen detection method was presented by Waller et al. group. Portable detec-
tion of Bacillus anthracis spores was done by amperometric immunoassay. Magnetic beads 
and glucose oxidase, both antibodies-conjugated were used as sensing sandwich-like material 
on gold matrix. Immunomagnetic spores separation and interferences removal from environ-
mental samples was done. For current signal, samples were incubated with glucose, horserad-
ish peroxidase and electron mediator. Target was captured by polyclonal antisera and signal 
was generated by monoclonal antibodies. Whole analysis took less than an hour. Authors 
wanted to increase the sensitivity of available lateral-flow devices and decrease analysis time 
comparing to ELISA and PCR. LOD was 500 spores and linear quantitative range from 5 × 103 
to 5 × 106 CFU/mL [69]. Gouma et al. have introduced novel isoprene sensor for influenza 
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virus detection. Infected patients generate more volatile products like nitric oxide (NO) and 
volatile organic compounds (VOCs) which are biomarkers in the disease detection. The secre-
tion comes from the alveolar and airway epithelium and leukocytes infiltrating the lungs. The 
device is a portable 3-sensor microsystem with rapid non-invasive screening. Measurement 
must be done as fast as disease symptoms are observed, for biomarkers changes in time obser-
vation. The sensor is able to detect three gases: isoprene, ammonia and NO in temperature 
control. The measurement relies on resistance changes of h-WO
3
 matrix with exposure to 
NO, NO
2
, isoprene and methanol at 350°C [33]. Influenza virus is notably investigated and 
described in the literature, as it is believed as the mother of all pandemics. Except conven-
tional detection methods, electrochemical techniques attract the scientific and market worlds. 
Very practical nature of these biosensors makes them applicable for POC [70]. Another elec-
trochemical biosensor was developed for dengue virus. Nascimento et al. have employed 
gold nanoparticles–polyaniline composite and immobilized with dengue serotype-specific 
primers. Chosen measurement technique was CV and EIS. Invented system was able to rec-
ognize the dengue serotype at picomolar concentration with high specificity and reproduc-




 nanowire in their amperometric sensing platforms 
for SARS virus detection. Authors have used antibody mimic proteins (AMPs), working as 
antibodies but smaller I size. The biomarker was viral nucleocapsid (N) protein. LOD of 1 nM 
was achieved in 10 min long analysis [72].
8. Application of biosensing technologies in telemedicine
Telemedicine is a widely used technology branch in patient’s healthcare. It exchanges the 
specialized care information from a distance via electronic communicators, provides health 
monitoring, increases the access to health services especially in places limited financially, 
like rural areas, and geographically, enhancing life quality. More specifically it can be video 
conversation, an email, by smartphone or other device, sometimes wireless tools. Common 
fields are telepsychiatry, teledermatology and teleradiology. It is definitely safe and effective 
in adult and pediatric medicine. Telemedicine is no more theory. A big part of implementa-
tion attempts succeed. The US survey in 2014 showed 86% of user’s satisfaction and 75% of 
willing attitude to telemedicine formats [73]. Survey form 2011 has reported very high tele-
medicine application. About 70% of radiology practices in US are in teleradiology form [74]. 
Treating patients at home seems to be beneficial for the family and the hospital itself. Also 
the continuous access to patients and physicians is very convenient. Teleconsultations can 
reduce the costs associated with the transport, waiting time and physical consultation price. 
Now it is possible to reach more patients with less time with the same or higher consulta-
tions satisfactory [75]. Moreover, ‘the medicare’ is a good marketing and promoting tool 
for potential new customers wins. Telemedicine cannot act perfectly, obviously. They were 
many cases of implementation failures, problems connected with operational costs, technol-
ogy integration lacks, the devices standard quality and safety. The service implementation 
is affected by factors like financing, technology, society acceptance and more. Necessary 
are operation trainings, user-friendly simple handlings and the commitment of specialists 
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(physicians, nurses) and patients. There are few types of services such as telemonitoring, 
teleconsultations, teleeducation, etc. [74, 76] offering home assistance and psychological 
support. Nowadays, the telemedicine usage reluctance still is observed, however decreases 
gradually, because these methods meet users need. Patients, especially elderly, use devices 
more readily and specialists enhance technology confidence. Helpful are program startups 
like guidelines published by The American Telemedicine Association (ATA) or The Center 
for Telehealth [74, 76].
As an example of telemedicine application, Shah et al. have proposed high-intensity model 
of care for illness care, expanding the access to seriously ill patients using real-time and 
store-and-forward approaches Authors have reduced the emergency department visits to 
34% over 1 year comparing to control group [77]. Newest Nature reports show a big inter-
est in telemedicine field, to fill the disease’s data-gaps, like in inflammatory bowel disease 
(IBD) case. Authors debate if IBD should be implemented in e-care or not. IBD is a chronic 
disease and its treatment is suboptimal, however implementation it to e-health may bring 
some profits. As it is relapsing and remitting disease, traditional clinical approach can be 
insufficient and not fast enough. By e-health approach, patients are believed to become 
active part in decisions-making when the first symptom occurs. Moreover, introducing IBD 
to telemedicine may be important financial impact, cost-saving due to eliminating outpa-
tient visits. However, validation costs must be considered too. Currently available e-cases 
are very small in numbers, still insufficient for global implementation. Real-life patient’s 
data are lacking [78].
Telemedicine is a great field to show biosensors potential. As their main goal is to be cheap, 
portable and user-friendly, they can be applied for everyday-based monitoring and in epi-
demics seasons, like during Ebola outbreak from 2014 in Africa, SARS in 2003 and pan-
demic influenza in 2009 or in moments where local medical centers suspect the danger and 
need reference center consultations. The next great appliance is for quarantine patients 
restricted to isolation [79] or any place with poor economic background or geographically 
difficult places to reach. Patients will be allowed to examine themselves by different inte-
grated systems, for example, by electronic device with easy to collect specimen and further 
send the results through mobile phone with specially designed app. For this case, the main 
target could be Africa with a spread of malaria, tuberculosis, HIV and Human Papilloma 
Virus (HPV). Current biomedical sensors for resource-limited countries suffering from 
these diseases are reported in Ref. [80]. Telemedicine have already found appliance in 
pathogens area. Beste et al. have described telemedicine support in Hepatitis C treatment 
in the American Veterans (VA) group. The main problem was not willingly prescribed anti-
virals by primary care providers due to health insurers or providers preference. The new 
program ECHO for promoting and improving telecare was launched offering video confer-
ences with specialists. After this adjustment, the rate of prescribed antivirals to reviewed 
patients by VA-ECHO has increased [81]. Telemedicine services have been implemented 
also in HIV/AIDS case. In literature reported, there was raising awareness in pharmacy 
trainees to optimize patient care [82] or in forming new systems like ‘VIHrtual Hospital’ 
with user-friendly interface [83].




The features for biosensors developments are mainly sensitivity, specificity and cost-effective-
ness detection. These parameters are critical for the high-quality sensing technology. The mod-
ern era requires combination of technological and biological approaches for more and more 
satisfactory devices. The next level is developing robust multi-task biosensor for long-term use. 
It is necessary due to therapeutics need, it means never ending patients and newly discovered 
pathogens. Unfortunately, hygiene and sanitation improvement did not reduce the mortality 
of infectious diseases. Current use of aptamers, peptides and other biomarkers is a key for 
accurate affection diagnosis. Sensing approaches are a strong factor for time-reduced and more 
effective treatment than before. The next success is molecules used not only for disease defini-
tion, but novel therapeutics, drug delivery, food and environmental monitoring. Invention of 
chemical, especially electrochemical, biosensors have found application in many fields, except 
everyday analysis, in sport medicine, doping control analysis and more, giving information 
about metabolism and physiology states. They offer rapid, real-time, very sensitive analysis. 
The next advantages, especially for electrochemical techniques, are miniaturization possibilities 
connected with reduces costs. Point-of-care devices and lab-on-chip technology win in the run. 
Electrochemical, mainly voltammetric and impedimetric, techniques are uncompetitive due to 
wide range of target analytes detection. This kind of biosensors keeps a promise for developing 
complete automatic sensing systems, with no need of sample pretreatment, fast analysis and 
interfaces with telecommunication devices (smartphones and tablets) and further with special-
ists. Telemedicine can be an answer for every patient suffering from lack of medical check-ups. 
It will be possible to detect many dysfunctions at first stages and prevent them with higher cure-
impact than treatment in far advanced infections. The ubiquitous smartphones distribution and 
connectivity changes the concept of public health. E-health solution meets the market need 
offering easy to operate system that fits in every pocket. Independent connectivity via Wi-Fi or 
Bluetooth will enable 24 h availability and updates depending on patient’s requirements.
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